Home
Conditions
Retroviridae Infections

Clinical trial condition

Retroviridae Infections

Explore clinical trials studying Retroviridae Infections. Study availability and eligibility vary by location and protocol.

5,659 public trials 307 recruiting studies

Refine in advanced search Browse all conditions

Retroviridae Infections trial results

Completed

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

NCT00002378

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: ASC Inc Anniston, Alabama, United States

CIGNA Phoenix, Arizona, United States

Arizona Clinical Research Ctr Inc Tucson, Arizona, United States

Univ of Arizona Tucson, Arizona, United States

View all 102 locations

View Trial Details

Completed

A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive Patients

NCT00000890

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States

Univ of California / San Diego Treatment Ctr San Diego, California, United States

Stanford at Kaiser / Kaiser Permanente Med Ctr San Francisco, California, United States

Stanford Univ Med Ctr Stanford, California, United States

View all 21 locations

View Trial Details

Completed

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

NCT00004852

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Phoenix Body Positive Phoenix, Arizona, United States

Pacific Oaks Research Beverly Hills, California, United States

AIDS Healthcare Foundation Los Angeles, California, United States

Tower ID Med Associates Los Angeles, California, United States

View all 66 locations

View Trial Details

Completed

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

NCT00002199

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States

View Trial Details

Completed

The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before

NCT00002291

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +25 more
Locations: Fisons Corp Rochester, New York, United States

View Trial Details

Completed

A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

NCT00002245

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +16 more
Locations: LAC / USC Med Ctr / Infectious Diseases Los Angeles, California, United States

View Trial Details

Completed

Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals

NCT00002087

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations: Stanford Univ Med Ctr Stanford, California, United States

View Trial Details

Completed

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.

NCT00002138

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations: Univ of California at San Francisco Gen Hosp San Francisco, California, United States

View Trial Details

Completed

A Study of Isoprinosine in Patients With Lymph Node Disease

NCT00002297

Conditions: AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +16 more
Locations: Newport Pharmaceuticals International Inc Laguna Hills, California, United States

View Trial Details

Completed

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

NCT00002231

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Univ of Pennsylvania Med Ctr Philadelphia, Pennsylvania, United States

View Trial Details

Retroviridae Infections

Retroviridae Infections trial results

Related conditions